Paper34722192
Guidelines for Prevention and Treatment of Chronic Hepatitis B.
Wang G and 1 other. J Clin Transl Hepatol, 2021. Cited by 74 papers, by iCite.
Cite this record
ConductScience Library. Guidelines for Prevention and Treatment of Chronic Hepatitis B. Papers, record 34722192. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34722192
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Trials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT05937178 | Real-world Study Optimizing Nucleotide-analogues | Background | ClinicalTrials.gov | |
| NCT06041022 | A Non-invasive Model to Predict Antiviral Therapy in Gray Zone of Chronic Hepatitis B | Background | ClinicalTrials.gov |
References215
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29056008 | [Clinical effect and safety of pegylated interferon-α-2b injection (Y shape, 40 kD) in treatment of HBeAg-positive chronic hepatitis B patients]. | Zhonghua Gan Zang Bing Za Zhi | 2017 | https://conductscience.org/library/papers/29056008 | PubMed |
| 2 | 27634134 | Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients. | Liver Int | 2016 | https://conductscience.org/library/papers/27634134 | PubMed |
| 3 | 29156044 | Characteristics, Prevention, and Management of Hepatitis B Virus (HBV) Reactivation in HBV-Infected Patients Who Require Immunosuppressive Therapy. | J Infect Dis | 2017 | https://conductscience.org/library/papers/29156044 | PubMed |
| 4 | 28668465 | Screening, monitoring, prevention, prophylaxis and therapy for hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation: a systematic review. | Clin Microbiol Infect | 2017 | https://conductscience.org/library/papers/28668465 | PubMed |
| 5 | 26727044 | Hepatitis B virus reactivation after withdrawal of prophylactic antiviral therapy in patients with diffuse large B cell lymphoma. | Leuk Lymphoma | 2016 | https://conductscience.org/library/papers/26727044 | PubMed |
| 6 | 28418296 | Prevention of Chronic Hepatitis B after 3 Decades of Escalating Vaccination Policy, China. | Emerg Infect Dis | 2017 | https://conductscience.org/library/papers/28418296 | PubMed |
| 7 | 26563120 | Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. | Hepatol Int | 2016 | https://conductscience.org/library/papers/26563120 | PubMed |
| 8 | 22052888 | Prevalence of and risk factors for hepatitis B viremia after spontaneous hepatitis B surface antigen seroclearance in hepatitis B carriers. | Clin Infect Dis | 2012 | https://conductscience.org/library/papers/22052888 | PubMed |
| 9 | 29456079 | Phase IV randomized clinical study: Peginterferon alfa-2a with adefovir or entecavir pre-therapy for HBeAg-positive chronic hepatitis B. | J Formos Med Assoc | 2018 | https://conductscience.org/library/papers/29456079 | PubMed |
| 10 | 28681347 | New concepts on the clinical course and stratification of compensated and decompensated cirrhosis. | Hepatol Int | 2018 | https://conductscience.org/library/papers/28681347 | PubMed |
| 11 | 12616450 | Natural history and prognosis of hepatitis B. | Semin Liver Dis | 2003 | https://conductscience.org/library/papers/12616450 | PubMed |
| 12 | 29353469 | Management of chronic hepatitis B patients in immunetolerant phase: what latest guidelines recommend. | Clin Mol Hepatol | 2018 | https://conductscience.org/library/papers/29353469 | PubMed |
| 13 | 27992681 | Hepatitis B virus core-related antigen as a surrogate marker for covalently closed circular DNA. | Liver Int | 2017 | https://conductscience.org/library/papers/27992681 | PubMed |
| 14 | 16673292 | Hepatitis B virus-related cirrhosis: natural history and treatment. | Semin Liver Dis | 2006 | https://conductscience.org/library/papers/16673292 | PubMed |
| 15 | 30876946 | Monotherapy with tenofovir disoproxil fumarate for adefovir-resistant vs. entecavir-resistant chronic hepatitis B: A 5-year clinical trial. | J Hepatol | 2019 | https://conductscience.org/library/papers/30876946 | PubMed |
| 16 | 7806171 | Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B. The EUROHEP Study Group on Hepatitis B Virus and Cirrhosis. | Hepatology | 1995 | https://conductscience.org/library/papers/7806171 | PubMed |
| 17 | 16557381 | Postoperative interferon alpha treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma: a randomized clinical trial. | J Cancer Res Clin Oncol | 2006 | https://conductscience.org/library/papers/16557381 | PubMed |
| 18 | 21907650 | Improving transient elastography performance for detecting hepatitis B cirrhosis. | Dig Liver Dis | 2012 | https://conductscience.org/library/papers/21907650 | PubMed |
| 19 | 25546679 | Antibody to hepatitis B core antigen levels in the natural history of chronic hepatitis B: a prospective observational study. | Medicine (Baltimore) | 2014 | https://conductscience.org/library/papers/25546679 | PubMed |
| 20 | 17628874 | Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase. | Hepatology | 2007 | https://conductscience.org/library/papers/17628874 | PubMed |
Cited by50
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 74 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42797837 | Weekly HBsAg Decline Dynamics During Combination Therapy with Interferon and Nucleos(t)ide Analogs: A Retrospective Real-World Study. | Viruses | 2026 | https://conductscience.org/library/papers/42797837 | PubMed |
| 42373438 | [Clinical study on the efficacy of Wuling capsules combined with nucleos(t)ide analogues in the treatment of low-level viremia patients with chronic hepatitis B]. | Zhonghua Gan Zang Bing Za Zhi | 2026 | https://conductscience.org/library/papers/42373438 | PubMed |
| 42168925 | Changes in myeloid-derived suppressor cells and cytokine expression during mother-to-child transmission prevention in HBeAg-positive pregnant women with chronic hepatitis B. | BMC Infect Dis | 2026 | https://conductscience.org/library/papers/42168925 | PubMed |
| 42096447 | Identification and functional analysis of key miRNAs and target genes associated with failure of HBV mother-to-child transmission prevention. | PLoS One | 2026 | https://conductscience.org/library/papers/42096447 | PubMed |
| 41495701 | Real-world efficacy of comprehensive measures against mother-to-child transmission of HBV in south-eastern Jiangsu, China. | BMC Infect Dis | 2026 | https://conductscience.org/library/papers/41495701 | PubMed |
| 41322205 | Optimized strategy of switching to tenofovir alafenamide fumarate treatment for nucleos(t)ide analogue experienced patients with chronic hepatitis B. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/41322205 | PubMed |
| 40995139 | Chemotherapy drugs do not affect the production of hepatitis B surface antibodies: A case report. | Oncol Lett | 2025 | https://conductscience.org/library/papers/40995139 | PubMed |
| 40887644 | Impact of stopping Tenofovir disoproxil fumarate at various times on elevated postpartum ALT levels and breastfeeding in pregnant women with chronic hepatitis B: a prospective observational cohort study. | BMC Pregnancy Childbirth | 2025 | https://conductscience.org/library/papers/40887644 | PubMed |
| 40636089 | Serum IP-10 increase correlated with PEG-IFNα response in nucleot(s)ide analogs-treated patients with chronic hepatitis B. | ILIVER | 2024 | https://conductscience.org/library/papers/40636089 | PubMed |
| 40385030 | Tenofovir disoproxil fumarate: safe and effective option for managing high-viral-load chronic hepatitis B. | Am J Transl Res | 2025 | https://conductscience.org/library/papers/40385030 | PubMed |
| 40344467 | Chemoprevention of Gastrointestinal Cancers: An Umbrella Review of Meta-Analyses of Randomized Controlled Trials and Cohort Studies. | Clin Transl Sci | 2025 | https://conductscience.org/library/papers/40344467 | PubMed |
| 40044428 | [Recent advances in epidemiology, prevention and treatment of hepatitis B in China]. | Zhonghua Gan Zang Bing Za Zhi | 2025 | https://conductscience.org/library/papers/40044428 | PubMed |
| 40003989 | Evaluation of the Potency of Repurposed Antiretrovirals in HBV Therapy: A Narrative Investigation of the Traditional Medicine Alternatives. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40003989 | PubMed |
| 39775320 | The prognosis and immune repertoire characteristics of HBsAg and anti-HBs double positive chronic hepatitis B patients. | Clin Exp Med | 2025 | https://conductscience.org/library/papers/39775320 | PubMed |
| 39744198 | Hepatitis B virus-induced cirrhosis: Mechanisms, global variations, and treatment advances. | World J Hepatol | 2024 | https://conductscience.org/library/papers/39744198 | PubMed |
| 39720865 | HBV-Induced Carcinogenesis: Mechanisms, Correlation With Viral Suppression, and Implications for Treatment. | Liver Int | 2025 | https://conductscience.org/library/papers/39720865 | PubMed |
| 39391516 | Trajectory and predictors of adherence to Nucleos(t)ide analogues medication among patients with chronic hepatitis B. | Heliyon | 2024 | https://conductscience.org/library/papers/39391516 | PubMed |
| 39328404 | Peripheral NK cell phenotypic alteration and dysfunctional state post hepatitis B subviral particles stimulation in CHB patients: evading immune surveillance. | Front Immunol | 2024 | https://conductscience.org/library/papers/39328404 | PubMed |
| 38798823 | A new approach to prevent, diagnose, and treat hepatitis B in Africa. | BMC Glob Public Health | 2023 | https://conductscience.org/library/papers/38798823 | PubMed |
| 38617970 | Development of novel prognostic models based on dynamic changes in risk factors for hepatitis B associated acute-on-chronic liver failure:a 10-year retrospective study. | Heliyon | 2024 | https://conductscience.org/library/papers/38617970 | PubMed |
Genes20
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34722192
GET https://conductscience.org/api/papers/v1/34722192/references?page=2